127 related articles for article (PubMed ID: 29401205)
1. Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Wu Y; Liu Y; Cai Z; Qin H; Li H; Su W; Wang Y; Qian H; Jiang L; Wu M; Pang J; Chen Y
Med Sci Monit; 2018 Feb; 24():736-742. PubMed ID: 29401205
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells.
Mejía-García TA; Portugal CC; Encarnação TG; Prado MA; Paes-de-Carvalho R
Cell Signal; 2013 Dec; 25(12):2424-39. PubMed ID: 23958999
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.
Yao X; Wu Y; Zhu M; Qian H; Chen Y
Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055
[TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y
Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339
[TBL] [Abstract][Full Text] [Related]
5. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
6. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
7. Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.
Wu Y; Cai Q; Li W; Cai Z; Liu Y; Li H; Pang J; Chen Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31350342
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis.
Kwon IK; Schoenlein PV; Delk J; Liu K; Thangaraju M; Dulin NO; Ganapathy V; Berger FG; Browning DD
Cancer; 2008 Apr; 112(7):1462-70. PubMed ID: 18260092
[TBL] [Abstract][Full Text] [Related]
9. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
10. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.
Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y
Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
12. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
13. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
14. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M
Atherosclerosis; 2011 May; 216(1):44-53. PubMed ID: 21316056
[TBL] [Abstract][Full Text] [Related]
16. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.
Jiang LU; Wu M; Wu Y; Lan T; Wang Y; Qian H; Chen Y
Oncol Lett; 2015 Jun; 9(6):2781-2786. PubMed ID: 26137146
[TBL] [Abstract][Full Text] [Related]
17. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits basolateral 10-pS Cl
Wu P; Gao Z; Ye S; Qi Z
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F755-F762. PubMed ID: 26764200
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
[TBL] [Abstract][Full Text] [Related]
20. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
